Skip to main content
. 2024 Jun 15;18(1):254. doi: 10.1007/s11701-024-01987-7

Table 8.

Peri-operative outcomes reported for transoral robotic surgery (TOR) (DFS; disease-free survival)

Robotic Vs Conventional Control procedure Number of patients Length of stay (Days) Complications Complication rate DFS
Robot Control Robot Control Robot Control Robot Control Robot Control
Li et al., [178] Open 2224 6697 4.3 5.1
Chung et al., [54] (anterior partial glossectomy) Open 68 3915 4.8 4 0 131 0.0% 3.3%
Chung et al., [54] (posterior pharyngectomy) Open 641 1426 3.7 5.2 21 71 3.3% 5.0%
Chung et al., [54] (posterior partial glossectomy) Open 147 747 3.54 5.06 14 37 9.5% 5.0%
Sano et al., [185] Open 68 236
Ford et al., [157] Open 65 65 89% 73%
White et al., [154] Open 64 64 3.8 8 26 55 40.6% 85.9% 74% 43%
Lee et al., [151] Open 27 30 14.6 24.6 95.70% 91.60%
Hammoudi et al., [158] Open 26 26 11 19 1 2
Total Average Total Average complication rate Average rate of DFS
3330 13,206 6.53 10.14 62 296 13.36% 24.80% 86.2% 69.2%
Un-paired, single tail T test (5%) 0.164 0.033* 0.314 0.126
Robotic Vs Radiotherapy Control procedure Number of patients Length of stay (days) Complications Complication rate DFS
Robot Control Robot Control Robot Control Robot Control Robot Control
Mahmoud et al., [173] Radiotherapy 559 1314
Nichols et al., [181] Radiotherapy 34 34 94 74 276.5% 217.6%
Smith et al., [165] CRT 42 38 94% 85%
Nichols et al., [187] Radiotherapy 34 34 88.20%
Total Total Average Complication Rate Average DFS Rate
669 1420 94 74 276.47% 217.65% 91.1% 85%
Robotic Only Number Length of stay (days) Complications Complication rate DFS Recurrence Recurrence rate
Van Loon et al., [159] 18 4.2 2 11.1% 86% 2 11.1%
Mercante et al., [162] 13 7 4 30.8%
Sethia et al., [175] 111 9 8.1%
Chan et al., [147] 4 4.25 0 0.0%
Chia et al., [148] 2015 205 10.2%
Durmus et al., [149] 22 0 0.0%
Durmus et al., [150] 3
Hans et al., [81] 3 14 0 0.0% 0 0.0%
Patel et al., [152] 47 5 10.6%
Tsang et al., 2013 1 0 0.0%
Almeida et al., [160] 410 94.50% 43 10.5%
Dabas et al., [161] 60 4.15 3 5.0% 64%
Razafindranaly et al., [164] 84 37 44.0% 2 2.4%
Aubry et al., [166] 178 12.6 87 48.9%
Fujiwara et al., [167] 10 8 0 0.0% 1 10.0%
Graneli et al., [168] 1 3 0 0.0% 0 0.0%
Duek et al., [169] 1 3 0 0.0% 0 0.0%
Lallemant et al., [172] 23 12.7
Rubek et al., [174] 30 5.3 6 20.0%
Doazan et al., [177] 122 90.20% 14 11.5%
Scott-Wittenbom et al., [179] 6
Hardy et al., [180] 1 0 0.0% 0 0.0%
Petruzzi et al., [182] 1 0 0.0%
Holcomb et al., [183] 2 0 0.0% 1 50.0%
Kubik et al., [184] 23 1 4.3%
D’Andrea et al., [186] 53 21 39.6% 46.10%
Virgilio et al., [188] 139 71.30%
Durmus et al. [156] 22 0 0.0%
Frenkel et al., [170] 425 273 64.2%
Gorphe et al., [171] 27 8 29.6%
Mockelmann et al., [163] 41 8 9 22.0%
Allessandrini et al., [176] 16 6.13 0.0%
Total Average Total Average complication rate Average DFS Average recurrence Overall recurrence rate
3912 7.10 661 13.6% 75.35% 6.5 9.44%
Overall
Number of patients Length of stay Complications Average complication rate Average DFS rate Average recurrence Overall recurrence rate
Robot Control Robot Control Robot Control Robot Control Robot Control Robot Control Robot Control
7911 14,626 6.90 10.14 817 370 22.3% 63.37% 81.18% 73.15% 6.5 9.44%